AzTrials
AzTrials

ShockDiPSNCT03043170

Diagnostic Investigation and Prediction of Shock

An observational study of Shock, run by Cardiff University at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background to the research Patients present to Emergency Departments (ED) with a spectrum of illness, many of which are life- threatening. The body has the ability to compensate in the early stages when things go wrong so that on the surface patients do not appear as sick as they really are. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Shock
What is being tested?
Ultrasound Cardiac Output Monitor
Type of treatment
Medical device
How many people
361 participants
Where
1 siteUnited Kingdom
Study dates
1 Mar 2017to 31 Aug 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Consecutive adult patients presenting to the ED of University Hospital of Wales (UHW) with a NEWS>3, requiring a trolley, and during research study periods

Who may be able to join

  • Adult patients aged ≥18 years
  • a NEWS≥3,
  • requiring a trolley

Who cannot join

  • <18 years

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Cardiff University

    Cardiff, S Glamorgan, CF14 4XN

Other trials in United Kingdom

About this study

Official title: Diagnostic Investigation and Prediction of Shock (The DiPS Study)

Background to the research Patients present to Emergency Departments (ED) with a spectrum of illness, many of which are life- threatening. The body has the ability to compensate in the early stages when things go wrong so that on the surface patients do not appear as sick as they really are. Under-diagnosis of severity of illness leads to under-treatment, unnecessary mortality, and unnecessary hospital costs. Earlier diagnosis and consequent treatment will result in prudent healthcare, cost-benefit and better patient outcomes.

Evaluating the true underlying patient haemodynamics such as cardiac output, cardiac power and peripheral pressures gives vital clues to the hidden seriousness of illness and is a guide to better management. Few EDs in the world assess such haemodynamics. After evaluating a haemodynamic protocol one centre in Australia was able to reduce its death rate for septic shock at 30 days from 38% to 7%. We would like to evaluate whether the same would occur if applied across EDs in Wales. However, before we can do that we need to strengthen our understanding of haemodynamics, and of relevant protocols and non-invasive devices that help us to acquire such information.

Read more

Study Design After ethics and institutional approval is obtained from we will conduct a prospective, single-centre, cohort study on 354 adult patients with possible shock associated with an acute illness or injury who present to the Emergency Department of the University Hospital of Wales, and follow them up for 7 days. 354 is a credible number to confirm that the strategy works.

Written consent will be obtained either from the patient or a relative wherever possible but a waiver of consent apply to patients who, because of confusion, unconsciousness or severe disability, may be unable to give consent. In these cases, consent will first be sought from a second doctor and/or nurse. Thereafter, consent will be obtained from the patient or a relative as soon as practically possible.

What you hope to discover

We expect to discover that:

  • Uscom variables predict 7-day survival and ICU admission
  • Uscom variables improve the detection and classification of shock
  • The LiPS definition can be improved.
  • The objective definition is better than doctors experience
  • Patients have a good experience and are satisfied with care
Read the detailed description

Patients frequently present to emergency departments (EDs) with critical illness and injury. Shock is a life-threatening emergency, which requires urgent and rapid assessment, diagnosis and treatment, and can be classified into distributive-septic (62%), distributive-non-septic (4%), hypovolaemic (16%), cardiogenic (16%) and obstructive (2%). Sepsis is the leading cause of in-hospital death, and approximately 80% of these patients are admitted through the ED. In Chinese patients presenting to an ED in Hong Kong we have previously derived and validated a simple, a priori, pragmatic, quantitative method for recognising and classifying shock - Li's Practical Shock (LiPS) tool. This method has been validated against ICU admission and early mortality. However, it was derived in a single population in a single centre, and requires further validation and refined in other settings. Further, it does not sub-classify patients beyond 'normal, cold and warm shock', does not guide next steps in treatment, and the assessment of the peripheries is very subjective.

Evaluating the true underlying patient haemodynamics such as cardiac output, cardiac power and peripheral pressures gives vital clues to the hidden seriousness of illness and is a guide to better management. Few EDs in the world assess such haemodynamics. After evaluating a haemodynamic protocol one centre in Australia was able to reduce its death rate for septic shock at 30 days from 38% to 7%. We would like to evaluate whether the same would occur if applied across EDs in Wales. However, before we can do that we need to strengthen our understanding of haemodynamics, and of relevant protocols and non-invasive devices that help us to acquire such information.

There are many unanswered questions such as:

  • Do Uscom-derived haemodynamic variables measured in the ED predict patients who at high risk of death, admission to ICU, and have shock?
  • Does a refined LiPS definition better predict mortality and ICU admission?
  • Do advanced haemodynamic predictors and/or refined LiPS predict better than experienced physicians the presence and classification of patients with shock, mortality and ICU admission?

This study will answer two main questions:

  1. What is the probability that a patient has shock?
  2. What type of shock does the patient have?

We propose:

  1. To investigate whether advanced haemodynamic variables using USCOM predict 7-day mortality and ICU admission.
  2. To investigate whether advanced haemodynamic variables using USCOM improve the detection and classification of shock.
  3. To validate and refine Li's a priori Pragmatic Shock (LiPS) method for detecting and classifying shock.
  4. To evaluate clinical experience for shock.
  5. To inform on the feasibility of future studies

After ethics and institutional approval is obtained from we will conduct a prospective, single-centre, cohort study on 354 adult patients with possible shock associated with an acute illness or injury who present to the Emergency Department of the University Hospital of Wales, and follow them up for 7 days. 354 is a credible number to confirm that the strategy works.

Written consent will be obtained either from the patient or a relative wherever possible but a waiver of consent apply to patients who, because of confusion, unconsciousness or severe disability, may be unable to give consent. In these cases, consent will first be sought from a second doctor and/or nurse. Thereafter, consent will be obtained from the patient or a relative as soon as practically possible.

The challenge is to discover a strategy that has a sensitivity >67% and specificity >72% for determining in-hospital mortality in clinically deteriorating or potentially shocked patients.

Conditions
Shock
Being tested
Ultrasound Cardiac Output Monitor
Keywords
Adults, Emergency Department, Haemodynamics, Resuscitation, Shock, Uscom
Medical subject headings
Shock, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound Cardiac Output MonitorDevice

    Also called USCOM®; USCOM Pty Ltd, NSW, Australia

    a device for assessing haemodynamics continuously and non-invasively using Doppler wave ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Composite of ICCU/all cause mortality

    Number of patients with admission to either ICU, or CCU, or death from any cause

    Measured: 7 days

Secondary outcomes (5)
  1. In-hospital mortality

    Number of patients with death from any cause in hospital

    Measured: 28 days

  2. 28-day mortality

    Number of patients with death from any cause within 28 days

    Measured: 28 days

  3. Admission to ICCU

    Number of patients with admission to either ICU or CCU

    Measured: 7 days

  4. ED shock

    Number of patients with shock in the ED defined according to LiPS criteria

    Measured: Within 4 hours of ED arrival

  5. Types of ED Shock

    Number of patients with ED shock categorised as either primarily restrictive or hypovolaemic, or cardiogenic or obstructive shock.

    Measured: Within 4 hours of ED arrival

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2017 (estimated)
  2. Study start1 Mar 2017
  3. Primary completion31 Aug 2018
  4. Study completion31 Aug 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
361 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03043170
Sponsor's protocol ID
CardiffU
Acronym
DiPS
Status last verified
Jan 2021
First submitted
2 Feb 2017
Last updated
5 Jan 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: No plan

Questions about this trial

What is this clinical trial studying?

An observational study of Shock, run by Cardiff University at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Composite of ICCU/all cause mortality (time frame: 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in